| Effects of the reduced form of coenzyme Q10 (ubiquinol) on semen parameters in men with idiopathic infertility: a double-blind, placebo controlled, randomized study 2012 · Group 1 · Men with idiopathic oligoasthenoteratozoospermia and unexplained infertility | 200 mg | 26 weeks | 114 |
| Effects of Ubiquinol and/or D-ribose in Patients With Heart Failure With Preserved Ejection Fraction 2022 · Ubiquinol group (Group 2) · Adults aged 50 years or older with heart failure with preserved ejection fraction | 600 mg | 12 weeks | 39 |
| Effect of Ubiquinol Intake on Defecation Frequency and Stool Form: A Prospective, Double-Blinded, Randomized Control Study 2019 · ubiquinol group · Patients with daily constipation or diarrhea symptoms; age and sex not specified | 150 mg | 12 weeks | 21 |
| Ubiquinol-10 supplementation improves autonomic nervous function and cognitive function in chronic fatigue syndrome 2016 · open-label ubiquinol-10 study · Patients with chronic fatigue syndrome | 150 mg | 8 weeks | 20 |
| Effect of gummy candy containing ubiquinol on secretion of saliva: A randomized, double-blind, placebo-controlled parallel-group comparative study and an in vitro study 2019 · ubiquinol group · Healthy adults under 65 with mild subjective mouth dryness or reduced moistness, without a clear xerostomia diagnosis | 100 mg | 8 weeks | 18 |
| Ubiquinol-10 supplementation improves autonomic nervous function and cognitive function in chronic fatigue syndrome 2016 · ubiquinol-10 group · Patients with chronic fatigue syndrome | 150 mg | 12 weeks | 17 |
| Ubiquinol Ameliorates Endothelial Dysfunction in Subjects with Mild-to-Moderate Dyslipidemia: A Randomized Clinical Trial 2020 · ubiquinol 200 mg/day · Men and post-menopausal women aged 35–65 years with mild-to-moderate dyslipidemia and moderate endothelial dysfunction | 200 mg | 8 weeks | 17 |
| Ubiquinol Ameliorates Endothelial Dysfunction in Subjects with Mild-to-Moderate Dyslipidemia: A Randomized Clinical Trial 2020 · ubiquinol 100 mg/day · Men and post-menopausal women aged 35–65 years with mild-to-moderate dyslipidemia and moderate endothelial dysfunction | 100 mg | 8 weeks | 15 |
| Randomized, double-blind, placebo-controlled pilot trial of reduced coenzyme Q10 for Parkinson's disease 2015 · Group A, ubiquinol-10 · Japanese patients with Parkinson's disease experiencing wearing off | 300 mg | 48 weeks | 14 |
| Randomized, double-blind, placebo-controlled pilot trial of reduced coenzyme Q10 for Parkinson's disease 2015 · Group B, ubiquinol-10 · Japanese patients with early Parkinson's disease, without levodopa, with or without a dopamine agonist | 300 mg | 96 weeks | 14 |
| Ubiquinol Improves Endothelial Function in Patients with Heart Failure with Reduced Ejection Fraction: A Single-Center, Randomized Double-Blind Placebo-Controlled Crossover Pilot Study 2020 · ubiquinol · Patients with stable heart failure with reduced ejection fraction (HFrEF); age and sex not reported | 400 mg | 90 days | 14 |
| Effect of liquid ubiquinol supplementation on glucose, lipids and antioxidant capacity in type 2 diabetes patients: a double-blind, randomised, placebo-controlled trial 2018 · liquid ubiquinol group · Adults with type 2 diabetes; age range and sex not specified | 100 mg | 12 weeks | 25 |
| Effect of reduced coenzyme Q10 (ubiquinol) supplementation on blood pressure and muscle damage during kendo training camp: a double-blind, randomized controlled study 2015 · CoQ10 group · Young male kendo athletes | 600 mg | 11 days | — |
| Evaluation of in vivo supplementation of 2660 mg D-aspartic acid and 200 mg ubiquinol and 10 mg zinc on different semen parameters in idiopathic male infertility: a randomized double blind placebo controlled study 2025 · Group (A) · Infertile men with idiopathic male infertility; age not reported | 200 mg | 90 days | 24 |
| Effects of a mitochondrial-targeted ubiquinol on vascular function and exercise capacity in chronic kidney disease: a randomized controlled pilot study 2023 · MTQ group · Patients with stage 3–4 chronic kidney disease; mean age 62 years | 20 mg | 4 weeks | — |
| Effects of Ubiquinol and/or D-ribose in Patients With Heart Failure With Preserved Ejection Fraction 2022 · Ubiquinol + D-ribose group (Group 4) · Adults aged 50 years or older with heart failure with preserved ejection fraction | 600 mg | 12 weeks | 38 |
| Ubiquinol supplementation in elderly patients undergoing aortic valve replacement: biochemical and clinical aspects 2020 · QH treated · Adults older than 70 years with severe aortic stenosis undergoing aortic valve replacement; men and women | 400 mg | 12 days | 24 |
| Effect of ubiquinol supplementation on biochemical and oxidative stress indexes after intense exercise in young athletes 2018 · ubiquinol · Healthy trained male rugby athletes, mean age 26 ± 5 years | 200 mg | 30 days | 21 |
| Comparative Bioavailability of Different Coenzyme Q10 Formulations in Healthy Elderly Individuals 2020 · Comparative product (CP) · Healthy adults aged 65 years or older, women and men | 100 mg | 1 day | 21 |
| Impact of oral ubiquinol on blood oxidative stress and exercise performance 2012 · CoQ10 supplement condition · Exercise-trained men and women aged 30–65 years without reported cardiovascular or metabolic disorders | 300 mg | 30 days | 15 |
| Increased oxidative stress and coenzyme Q10 deficiency in juvenile fibromyalgia: amelioration of hypercholesterolemia and fatigue by ubiquinol-10 supplementation 2013 · Ubiquinol-10 supplementation · Juvenile patients with fibromyalgia | 100 mg | 12 weeks | 10 |
| Ubiquinol is superior to ubiquinone to enhance Coenzyme Q10 status in older men 2018 · ubiquinol supplement · older men; age range and health condition not reported | 200 mg | 2 weeks | 10 |
| Ubiquinol Effects on Antiphospholipid Syndrome Prothrombotic Profile: A Randomized, Placebo-Controlled Trial 2017 · Qred · Patients with antiphospholipid syndrome (APS) | 200 mg | 30 days | — |
| Ubiquinol (reduced coenzyme Q10) as a metabolic resuscitator in post-cardiac arrest: A randomized, double-blind, placebo-controlled trial 2021 · ubiquinol group · patients successfully resuscitated from cardiac arrest; age and sex not specified | 600 mg | 7 days | — |
| Beneficial Effect of Ubiquinol on Hematological and Inflammatory Signaling during Exercise 2020 · Ubiquinol group · Healthy, well-trained firemen; age and sex not specified | 200 mg | 2 weeks | 50 |
| Short-term ubiquinol supplementation reduces oxidative stress associated with strenuous exercise in healthy adults: A randomized trial 2016 · Ubiquinol (experimental group) · Healthy, well-trained adults who were not at an elite level | 200 mg | 2 weeks | — |
| Ubiquinol supplementation modulates energy metabolism and bone turnover during high intensity exercise 2020 · ubiquinol group · Healthy, well-trained firemen; age and sex not specified | 200 mg | 2 weeks | — |
| Effect of ubiquinol on electrophysiology during high-altitude acclimatization and de-acclimatization: A substudy of the Shigatse CARdiorespiratory fitness (SCARF) randomized clinical trial 2024 · ubiquinol group · participants undergoing high-altitude acclimatization and de-acclimatization | 200 mg | — | — |
| Effect of carni Q-gel (ubiquinol and carnitine) on cytokines in patients with heart failure in the Tishcon study 2007 · group A (carni Q-gel) · Patients with class II–IV heart failure | 270 mg | 12 weeks | 31 |